지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.1
- 수록면
- 574 - 580 (7page)
이용수
초록· 키워드
오류제보하기
Background/Aims: The relationships between serum procalcitonin, inflammatory bowel disease (IBD) and intestinal Behçet’s disease (BD) have not been completely determined.
We aimed to evaluate the usefulness of measuring serum procalcitonin levels to assess disease activity and infection stage in patients with IBD and intestinal BD. Methods: We retrospectively analyzed clinical data from 129 patients with IBD and intestinal BD for whom serum procalcitonin and Creactive protein (CRP) levels were measured between January 2006 and February 2013. Results: The median serum procalcitonin levels in the IBD and intestinal BD with septic shock or sepsis (n=8), with localized infection (n=76), and without infection (n=45) were 3.46 ng/mL (range, 0.17 to 63.66 ng/mL), 0.22 ng/mL (range, 0.05 to 140.18 ng/mL), and 0.07 ng/mL (range, 0.00 to 31.50 ng/mL), respectively (p=0.001). The serum CRP levels in the IBD and intestinal BD patients did not differ according to the infection stage.
Variations in serum procalcitonin levels were not observed in the IBD and intestinal BD patients with different disease activities. Conclusions: Serum procalcitonin levels may not be affected by IBD and intestinal BD activity itself, although they may be affected by concomitant infection. Serum procalcitonin measurements could be more useful than CRP in determining the infection stage that reflects the severity of infection in IBD and intestinal BD patients.
목차
등록된 정보가 없습니다.
참고문헌 (34)
참고문헌 신청
Jung YS / 2011 / Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet’s disease / Inflamm Bowel Dis 17:2130~2137
Park JJ / 2009 / Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease / Dig Dis Sci 54:1525~1531
김경옥 / 2014 / Does Carotid Intima-Media Thickness Increase in Patients With Inflammatory Bowel Disease? / Intestinal research 12(4):293~298
Lidar M / 2009 / The role of infection in inflammatory bowel disease: initiation, exacerbation and protection / Isr Med Assoc J 11:558~563
박재준 / 2013 / Outcome Predictors for Intestinal Behçet’s Disease / Yonsei Medical Journal 54(5):1084~1090
Park JJ / 2009 / Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease / Dig Dis Sci 54:1525~1531
김경옥 / 2014 / Does Carotid Intima-Media Thickness Increase in Patients With Inflammatory Bowel Disease? / Intestinal research 12(4):293~298
Lidar M / 2009 / The role of infection in inflammatory bowel disease: initiation, exacerbation and protection / Isr Med Assoc J 11:558~563
박재준 / 2013 / Outcome Predictors for Intestinal Behçet’s Disease / Yonsei Medical Journal 54(5):1084~1090
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Optimal diagnosis and disease activity monitoring of intestinal Behçet’s disease
Intestinal research
2017 .01
-
Intestinal Behçet’s Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
Yonsei Medical Journal
2016 .01
-
Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
대한류마티스학회지
2021 .01
-
Clinical utility of procalcitonin in severe odontogenic maxillofacial infection
Maxillofacial Plastic Reconstructive Surgery
2021 .01
-
Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
Gut and Liver
2018 .01
-
Clinical Value of Procalcitonin in Patients with Spinal Infection
대한신경외과학회지
2015 .01
-
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Immune Network
2017 .02
-
Treatment and outcomes: medical and surgical treatment for intestinal Behçet’s disease
Intestinal research
2017 .01
-
장내 미생물과 염증장질환
대한의사협회지
2021 .09
-
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
Yonsei Medical Journal
2024 .05
-
우리나라 염증장질환의 현황
대한의사협회지
2021 .09
-
Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
Intestinal research
2020 .01
-
Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
Intestinal research
2022 .04
-
Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
Intestinal research
2023 .04
-
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Intestinal research
2022 .10
-
Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
대한류마티스학회지
2020 .01
-
Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study
Gut and Liver
2017 .07
-
염증장질환의 역학 및 진단
대한의사협회지
2021 .09
-
Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
Intestinal research
2022 .10
-
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
Gut and Liver
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0